GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $213,000 | -5.3% | 5,348 | -12.5% | 0.00% | 0.0% |
| Q4 2020 | $225,000 | -6.6% | 6,113 | -4.5% | 0.00% | 0.0% |
| Q3 2020 | $241,000 | -14.2% | 6,404 | -7.1% | 0.00% | 0.0% |
| Q2 2020 | $281,000 | -3.1% | 6,892 | -9.9% | 0.00% | -50.0% |
| Q1 2020 | $290,000 | -11.0% | 7,648 | +10.4% | 0.00% | +100.0% |
| Q4 2019 | $326,000 | -7.4% | 6,930 | -15.9% | 0.00% | -50.0% |
| Q3 2019 | $352,000 | -24.5% | 8,238 | -29.3% | 0.00% | 0.0% |
| Q2 2019 | $466,000 | -25.7% | 11,649 | -22.4% | 0.00% | -33.3% |
| Q1 2019 | $627,000 | +17.9% | 15,009 | +7.9% | 0.00% | +50.0% |
| Q4 2018 | $532,000 | -33.7% | 13,914 | -30.3% | 0.00% | -33.3% |
| Q3 2018 | $802,000 | -12.2% | 19,957 | -11.8% | 0.00% | 0.0% |
| Q2 2018 | $913,000 | -16.2% | 22,639 | -18.9% | 0.00% | -25.0% |
| Q1 2018 | $1,090,000 | +19.8% | 27,904 | +8.8% | 0.00% | +33.3% |
| Q4 2017 | $910,000 | -7.6% | 25,647 | +5.7% | 0.00% | 0.0% |
| Q3 2017 | $985,000 | +19.8% | 24,261 | +27.2% | 0.00% | 0.0% |
| Q2 2017 | $822,000 | -3.1% | 19,068 | -5.1% | 0.00% | 0.0% |
| Q1 2017 | $848,000 | +3.7% | 20,102 | -5.3% | 0.00% | 0.0% |
| Q4 2016 | $818,000 | -37.4% | 21,233 | -29.9% | 0.00% | -40.0% |
| Q3 2016 | $1,307,000 | -0.8% | 30,311 | -0.3% | 0.01% | 0.0% |
| Q2 2016 | $1,318,000 | +17.4% | 30,407 | +9.8% | 0.01% | +25.0% |
| Q1 2016 | $1,123,000 | +2.1% | 27,703 | +1.6% | 0.00% | 0.0% |
| Q4 2015 | $1,100,000 | -2.3% | 27,256 | -7.0% | 0.00% | 0.0% |
| Q3 2015 | $1,126,000 | -10.5% | 29,293 | -3.0% | 0.00% | -20.0% |
| Q2 2015 | $1,258,000 | -8.1% | 30,210 | +1.8% | 0.01% | 0.0% |
| Q1 2015 | $1,369,000 | -70.1% | 29,672 | -72.3% | 0.01% | -68.8% |
| Q4 2014 | $4,572,000 | -13.1% | 106,961 | -6.6% | 0.02% | -20.0% |
| Q3 2014 | $5,264,000 | -9.0% | 114,515 | +5.8% | 0.02% | -13.0% |
| Q2 2014 | $5,786,000 | +5.1% | 108,197 | +5.0% | 0.02% | +4.5% |
| Q1 2014 | $5,504,000 | +57.2% | 103,015 | +47.6% | 0.02% | +37.5% |
| Q3 2013 | $3,501,000 | +6.5% | 69,791 | +6.1% | 0.02% | 0.0% |
| Q2 2013 | $3,286,000 | – | 65,756 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |